| Note: |
STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Recombinant-Human HIV-1 gp160-protein was developed from NA. For use in research applications. |
| Conjugation: |
Unconjugated |
| Formulation: |
0.2 µm filtered 100mM PBS, pH4.5, 10mM tris HCL., 300mM Imidiasole, 8M Urea |
| Storage Instruction: |
Can be stored in working aliquots at 4°C C for one month, or at-20°C C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. NA |
| Endotoxin: |
Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than.1 ng/µg (1EU/µg). NA |
| Specificity: |
Immunoreative with sera of infected HIV individuals |
| Immunogen: |
Recombinant HIV gp160 encodes the immunodominant sequences of the HIV Transmembrane Glycoprotein 160. NA |
| Background | Recombinant HIV gp160 is fused to an Beta-galactosidase purification tag and migrates as 58kDa on PAGE. |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
